Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00314522
First received: April 11, 2006
Last updated: December 8, 2011
Last verified: December 2011
  Purpose

This study performed a retrospective analysis of patient images to develop software in determining dose delivered for each fraction treatment.


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 5
Study Start Date: September 2005
Estimated Study Completion Date: March 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clniic

Criteria

Inclusion Criteria:

  • Subject 18 years of age and over
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00314522

Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Investigators
Principal Investigator: Gino Fallone, PhD AHS Cancer Control Alberta
  More Information

No publications provided

Responsible Party: AHS Cancer Control Alberta
ClinicalTrials.gov Identifier: NCT00314522     History of Changes
Other Study ID Numbers: EX-0003
Study First Received: April 11, 2006
Last Updated: December 8, 2011
Health Authority: Canada: Health Canada

ClinicalTrials.gov processed this record on April 22, 2014